G-CSF treatment of donor mice induced low-density splenic granulocytes, which inhibit experimental GVHD (47) and the administration of GVHD-suppressing drug rapamycin, results in expansion of PMN-MDSCs (48) indicating that PMN-MDSCs are the major suppressor population. This evidence concerns the gene CSF3 and graft versus host disease.